SOPHARMA (SPH): SOPHARMA AD (9/2025) Sales revenues for January 2025 - raport 9/2025
Raport ESPI
Report no 9/2025
Podstawa prawna: art. 56. 1. 2 of Act on Public Offering.
Sofia, Bulgaria, February 20, 2025 - According to the requirements of Art. 100t of the Law on Public Offering of Securities (LPOS), "Sopharma" AD (SFA: "Bulgarian Stock Exchange" AD, SPH: Warsaw Stock Exchange) notifies, that for January 2025 the Company recorded an increase in sales of 7% compared to the same month of the previous year, incl. 6% increase in domestic sales and 8% increase in export sales.
